Drugs / SNG100
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04615962 | Jan 2021 → Jan 2022 | atopic eczema | Seanergy Dermatology Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SNG100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04615962 ↗ |
| Modality | Other / unclassified | “A combination of low potency steroid and skin barrier repair agent” NCT04615962 ↗ |
| Route | Topical | “Topical Cream SNG100” NCT04615962 ↗ |